Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1234.60
-10.90 (-0.88%)
< Home < Back

Dr. Reddy’s Laboratories gets approval for phase 3 trials of Sputnik V Covid-19 vaccine

Date: 12-01-2021

Dr. Reddy’s Laboratories has got approval from the independent Data and Safety Monitoring Board (DSMB) for phase 3 trials of Russia's Sputnik V Covid-19 vaccine. DSMB’s clearance is based on the safety data from the phase 2 clinical trial. The company is running the clinical trial for the Sputnik V vaccine in India in partnership with the Russian Investment Development Fund.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.